Glitaris 7.5 Tablet

Glitaris 7.5 Tablet is a prescription diabetes medicine that contains pioglitazone 7.5 mg in each tablet. It belongs to the thiazolidinedione class, also called TZDs, and is used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. Glitaris 7.5 Tablet is not for type 1 diabetes or diabetic ketoacidosis. It is the lower-strength tablet in the Glitaris range and may be chosen when a doctor wants a more gradual dose adjustment.

How it works: Pioglitazone in Glitaris 7.5 Tablet helps your body respond better to insulin, so glucose can move out of the bloodstream and into the cells more effectively. As a tablet, it is taken by mouth and works over time rather than by quickly lowering sugar right after a dose.

Glitaris 7.5 Tablet provides 7.5 mg pioglitazone per tablet, which is lower than Glitaris 15 Tablet and Glitaris 30 Tablet. That makes it useful for people who need a smaller, carefully assessed dose, such as when a doctor wants to reduce the chance of fluid retention or other dose-related side effects. Because it is a lower strength, it is not a "starter" for everyone by default; the right dose depends on your blood sugar goals and medical history.

• Type 2 diabetes mellitus
• Improving blood sugar control with diet and exercise
• May be used alone or with other diabetes medicines
• Helps reduce insulin resistance

• Swallow Glitaris 7.5 Tablet whole with water.
• Take it once daily at the same time each day unless your doctor tells you otherwise.
• It can be taken with or without food.
• Do not crush, chew, or split the tablet unless your pharmacist or doctor says it is okay.
• Keep following your diabetes meal plan and activity plan while taking this tablet.

Each Glitaris 7.5 Tablet contains pioglitazone 7.5 mg. This strength may be taken once daily, but the exact schedule and whether a higher total daily dose is needed depends on your doctor’s assessment and your response to treatment; the usual maximum total daily dose of pioglitazone is 45 mg per day. Do not change your dose on your own, because the doctor chooses the dose based on blood sugar, side effects, and other medicines you use.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Pioglitazone may include:

• Swelling in the legs or feet
• Weight gain
• Headache
• Muscle aches
• Upper respiratory symptoms such as a runny nose or sore throat
• Mild stomach upset
• These effects can occur at any strength, but fluid retention may be more important to watch for with pioglitazone

• Do not use Glitaris 7.5 Tablet to treat type 1 diabetes or diabetic ketoacidosis.
• Tell your doctor if you have heart failure, fluid retention, or a history of swelling, because pioglitazone can worsen these problems.
• This lower strength may be chosen to reduce side effects, but even 7.5 mg can still cause weight gain and edema.
• Use caution if you drink alcohol, because it can affect blood sugar and make diabetes control less predictable.
• If you take insulin or another diabetes medicine, your risk of low blood sugar may be higher.
• Tell your doctor if you have bladder cancer, blood in the urine, or unexplained urinary symptoms.
• Do not drive if you feel dizzy or if your blood sugar is too low or too high.

• Insulin, which can increase the risk of fluid retention and low blood sugar when combined with pioglitazone
• Sulfonylureas such as glimepiride or glyburide, which can raise low blood sugar risk
• Strong CYP2C8 inhibitors such as gemfibrozil, which may increase pioglitazone levels
• CYP2C8 inducers such as rifampin, which may reduce pioglitazone effectiveness
• Alcohol, which can make blood sugar control less stable

Store Glitaris 7.5 Tablet at room temperature in the original strip or box, away from excess heat, moisture, and light.